Advertisement
Advertisement
REGN
Regeneron Pharmaceuticals Inc
973.36
USDSponsored
+12.10
+1.26%
Nov 03, 16:00 UTC -5
Closed
Pre-Market
969.75
-3.61
-0.37%
Regeneron Pharmaceuticals Inc (REGN)
Regeneron Pharmaceuticals Inc Financial Snapshot
| Market Cap | 100.32B |
| Beta | 0.16 |
| Earnings Per Share (EPS) | 45.29 |
| Price-to-Book (P/B) Ratio | 2.64 |
| Operating Margin | 27.17% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | 20.87 |
| Return on Equity (ROE) | 13.47% |
| Current Ratio | -- |
| Free Cash Flow | 0.00 |
